• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Kansas Considers Regulating Mental Health Drugs for Medicaid Patients

Article

Kansas health regulators are working to repeal a 2002 law prohibiting the state from regulating mental health drugs used for treating Medicaid patients. Doing so could potentially save the state about $7 million.

During this legislative session, Kansas health regulators have been working to repeal a 2002 law prohibiting the state from regulating mental health drugs used for treating Medicaid patients. The state, however, can regulate other drugs for treating heart disease, high blood pressure or cancer.

Repealing the law would give the state the ability to limit access to drugs that could pose safety risks or be more expensive by requiring prior authorization for prescriptions.

It could potentially save the state about $7 million, a figure hotly contested by mental health advocates.

Read more: http://bit.ly/1E5JzWe

Source: Kansas City Star

Read more here: http://www.kansascity.c/news/government-politics/article13044425.html#storylink=cpy

Read more here: http://www.kansascity.com/news/government-politics

/article13044425.html#storylink=cpy

Related Videos
Dr Sophia Humphreys
Robert Zimmerman, MD
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Ryan Stice, PharmD
Raajit Rampal, MD, PhD, screenshot
Leslie Fish, PharmD.
Ronesh Sinha, MD
Adam Colborn, JD
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.